Sex Differences in Melanoma Survival are Not Related to Mitotic Rate of the Primary Tumor

[1]  J. Coebergh,et al.  Sex is an independent prognostic indicator for survival and relapse/progression-free survival in metastasized stage III to IV melanoma: a pooled analysis of five European organisation for research and treatment of cancer randomized controlled trials. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  J. Coebergh,et al.  Superior outcome of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Research and Treatment of Cancer phase III trials. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Gershenwald,et al.  Update on the melanoma staging system: The importance of sentinel node staging and primary tumor mitotic rate , 2011, Journal of surgical oncology.

[4]  C. Tzen,et al.  Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma , 2011, Pigment cell & melanoma research.

[5]  V. Sondak,et al.  Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  I. Bartenjev,et al.  Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients , 2011, Melanoma research.

[7]  Q. Mi,et al.  BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. , 2011, The Journal of investigative dermatology.

[8]  R. Scolyer,et al.  BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site , 2011, Pigment cell & melanoma research.

[9]  G. Mann,et al.  Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Coebergh,et al.  Gender differences in melanoma survival: female patients have a decreased risk of metastasis. , 2011, The Journal of investigative dermatology.

[11]  K. Flaherty,et al.  Large-Scale Analysis of KIT Aberrations in Chinese Patients with Melanoma , 2011, Clinical Cancer Research.

[12]  M. Rosińska,et al.  Cutaneous melanoma with nodal metastases in elderly people , 2010, International journal of dermatology.

[13]  J. Coebergh,et al.  Reactive oxygen species and melanoma: an explanation for gender differences in survival? , 2010, Pigment cell & melanoma research.

[14]  C. Navarro,et al.  Cancer survival in Spain: estimate for nine major cancers. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  Jeffrey E Gershenwald,et al.  Final version of 2009 AJCC melanoma staging and classification. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  G. Gatta,et al.  The advantage of women in cancer survival: an analysis of EUROCARE-4 data. , 2009, European journal of cancer.

[17]  C. Garbe,et al.  Age and gender are significant independent predictors of survival in primary cutaneous melanoma , 2008, Cancer.

[18]  H. Olsson,et al.  Prognostic factors in invasive cutaneous malignant melanoma: a population-based study and review , 2001, Melanoma research.

[19]  A. Stewart,et al.  Superior survival of young women with malignant melanoma. , 1998, American journal of surgery.

[20]  D. Morton,et al.  Prognostic factors in 1,521 melanoma patients with distant metastases. , 1995, Journal of the American College of Surgeons.

[21]  J. Thompson,et al.  Survival superiority of females with melanoma. , 1994, Archives of surgery.

[22]  H. Seigler,et al.  Survival superiority of females with melanoma. A multivariate analysis of 6383 patients exploring the significance of gender in prognostic outcome. , 1994, Archives of surgery.

[23]  Q. Vuong.  Likelihood Ratio Tests for Model Selection and Non-Nested Hypotheses , 1989 .

[24]  V. McGovern,et al.  Malignant melanoma: Influence of site of lesion and age of patient in the female superiority in survival , 1980, Cancer.

[25]  K. Flaherty,et al.  Prevalence of BRAF V600E mutation in Chinese melanoma patients: large scale analysis of BRAF and NRAS mutations in a 432-case cohort. , 2012, European journal of cancer.

[26]  M. Janssen-Heijnen,et al.  Superior survival of females among 10,538 Dutch melanoma patients is independent of Breslow thickness, histologic type and tumor site. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  A. Cochran,et al.  The Classification of Malignant Melanoma, its Histological Reporting and Registration: A Revision of the 1972 Sydney Classification , 1986, Pathology.